FORTREA HOLDINGS INC (FTRE)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for FTRE
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| FTRE | Chief Executive Officer and Director | 48 | ["General Management and Business Operations","CEO Experience","Finance/Accounting","Mergers and Acquisitions","Risk Management","International Business","Healthcare/Drug Development","Spin Experience","More than 25 years of experience in the CRO, pharmaceutical, and biotech industries","General manager","Management consultant","Commercial leader","Entrepreneur","Co-Founder and Chief Executive Officer of Launch Therapeutics","Former Global Head of PPD Biotech at PPD, Inc.","Chief Commercial Officer and Executive Vice President at PPD","Ran the global life sciences business unit at Gerson Lehrman Group","Consultant at McKinsey & Company","Bachelor of Science and Master of Science in Biomedical Engineering from Johns Hopkins University","Master of Business Administration from the Wharton School at the University of Pennsylvania"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Mr. Thakral has served as our Chief Executive Officer and a member of our Board of Directors since August 2025. Mr. Thakral has more than 25 years of experience in the CRO, pharmaceutical, and biotech industries as a general manager, management consultant, commercial leader and entrepreneur. He previously served as Co-Founder and Chief Executive Officer of Launch Therapeutics since its founding in March 2022. From July 2016 to February 2022, Mr. Thakral served in increasing levels of seniority at PPD, Inc. ( PPD ), from Global Head of PPD Biotech to Chief Commercial Officer and Executive Vice President of Peri- and Post-Approval Services at PPD. Before PPD, Mr. Thakral ran the global life sciences business unit at Gerson Lehrman Group from March 2014 to June 2016 and served as a consultant at McKinsey & Company from August 2006 to March 2014, where he was an associate principal in the healthcare practice, counselling senior management and CEOs of global pharmaceutical and biotechnology companies. Mr. Thakral currently serves on the board of directors of Orsini Specialty Pharmacy, a leader in pharmacy solutions for rare disease and complex therapy programs and earned his Bachelor of Science and Master of Science in Engineering in Biomedical Engineering from Johns Hopkins University and his Master of Business Administration from the Wharton School at the University of Pennsylvania.